< Back to companies
Percutek Therapeutics

Percutek Therapeutics

Aortic repair, minimally invasive

Beijing, China

Percutek Therapeutics develops and manufactures medical devices, such as stent-grafts, for the non-invasive interventional diagnosis and treatment of cardiovascular diseases.

Share
Shareable draft
Hero image for Percutek Therapeutics
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in Percutek Therapeutics

1 engagement

How We Help

Problem Statement

To address the need for high-quality products and solutions in non-invasive interventional cardiovascular diagnosis and treatment for various vascular diseases.

Core Technology

Stent-grafts designed with special weaving techniques that reduce membrane penetration force while maintaining structural integrity.

Key Differentiators

Proprietary weaving techniques for stent-grafts that reduce membrane penetration force while maintaining structural integrity.

Clinical Focus

Cardiology; Interventional Radiology

Company Info

Business Model
B2B
Total Funding
Only accessible to MedStartr community members. Join now
Website
www.huamaitaike.com

Categories

OtherDevices & MedTechImplantable Devices

Disease Areas

Technologies

Medical DevicesStent-GraftInterventional Cardiology

Clinical & IP

🔬

Clinical Validation

First-in-human case published in European Heart Journal (2024) demonstrating successful TEVAR with in situ fenestration. Clinical trial data shows 95.8% success rate for AAA repair. SIS graft in multicenter clinical trials. Published in peer-reviewed journals.

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Percutek Therapeutics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Percutek Therapeutics

1 engagement

💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free